Diversity, Outreach and Inclusion Scholarship Fund
The Boston Psychedelic Research Group (BPRG) is supporting the California Institute of Integral Studies (CIIS) through a scholarship fund that will support members of the new cohort of the Center for Psychedelic Therapies and Research (CPTR) Certificate Program in Boston. Specifically, we want to assist:
1-BIPOC (Black, Indigenous, and People of Color) Students,
2-LGBTQ students, and
3-Therapists who are working with marginalized communities.
We are asking everyone who is able to help to consider donating so we can get more people trained, which will in turn heal more people who could eventually benefit from these therapies. The best part is that BPRG Board of Directors will match every dollar you donate and THEN, CIIS will match everything we (BPRG Board and Members) raise combined (up to $50,000). So if you donate $50 it will QUADRUPLE into $200 which would go directly to deserving students in the Boston cohort.
Both the BPRG and CIIS are 501c3's so these will be tax-deductible donations. We are hoping over time to build up a self-sustaining fund to continue giving these scholarships to students who need it.
About the BPRG
The Boston Psychedelic Research Group is a Massachusetts nonprofit corporation committed to the promotion, dissemination, and advancement of psychedelic research. Based in Cambridge, Massachusetts, the BPRG started in 2018 over an informal dinner. Years later we have over 600 members and are growing both in Boston and globally. We are a hub for education about the powerful benefits psychedelic-assisted therapy can have in the treatment of a wide variety of mental health issues. We do this primarily by holding monthly meetings where attendees can gather and converse, hear a prominent speaker share his or her work, and participate in a Q&A session.
The California Institute of Integral Studies (CIIS) is an accredited non-profit institution of higher education and research where students come to learn experientially what it means to be human in a rapidly changing world. Founded in 1968, CIIS has an annual enrollment of approximately 1,500 students pursuing degrees in 25 academic programs in its schools of Professional Psychology and Health, Consciousness and Transformation, Traditional Chinese Medicine, and Undergraduate Studies. The university operates eight award-winning clinics throughout San Francisco offering low-cost or no-cost mental healthcare and acupuncture to more than 6,000 clients annually. In addition, CIIS Public Programs present an exciting array of lectures, conversations, performances, workshops, and conferences for both academic and general audiences. These transformative gatherings at the nexus of mental health, spirituality, ecology, social justice, and creativity serve and strengthen diverse communities throughout the Bay Area, attracting more than 11,000 attendees and 365,000 podcast listeners each year.
About the CPTR Program
To address the demand for trained psychotherapists to work in the expanding field of psychedelic studies, CIIS created the Center for Psychedelic Therapies and Research (CPTR) in 2015. CPTR is directed by clinical psychologist Dr. Janis Phelps. CPTR’s mission is to invite cohorts of licensed psychotherapists, medical professionals, and ordained clergy to become researchers, therapists, and practitioners in legal psychedelic clinical studies. Because it is housed within a university, CPTR is the first and only academically accredited training program for psychedelic-assisted therapies in the world. Deploying CIIS’ institutional expertise in psychotherapy education, the CPTR certificate encompasses all aspects of learning: intellectual/didactic, personal/experiential, and applied. The CPTR certificate program is the world’s largest collaborative program focusing on psychedelic studies within a non-medical graduate university.
About Psychedelic-Assisted Therapies
Around 450 million people across the globe currently suffer from mental health conditions, placing mental disorders among the leading causes of ill health and disability world-wide. Psychedelic-assisted therapy has shown incredible potential to treat a range of mental health conditions including depression, addiction, and trauma. Results from a range of clinical trials at leading universities and research centers have shown MDMA and psilocybin-assisted therapy to be dramatically more effective than existing psychiatric or pharmacological treatments. As these drugs get closer to reclassification and legalization through Food and Drug Administration (FDA) trials and legislative efforts, the major gap in delivering treatment to the tens of millions of patients who need it will be the lack of trained psychedelic-assisted therapists.
It is important to note that at no time does the BPRG or CIIS promote or require the recreational use of psychedelic drugs in any manner. Students taking the certificate program learn about the competencies required of therapist guides in federally-approved medical treatment and psychedelic research.